Presentation TCTAP 2013 The Future Is: New Antiplatelet Agents, Selective Platelet Function Testing, and Patient-Specific DAPT Duration Presenter: Matthew J. Price April 24, 2013
Presentation TCTAP 2013 Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive Presenter: Adnan Kastrati April 24, 2013
Presentation TCTAP 2012 Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI: Presenter: Gregg W. Stone April 26, 2012